Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Wanbury Ltd.
₹234.83
₹228.50
₹241.00
₹161.50
₹329.70
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 162.45 | 160.06 | 163.18 | 172 | 133.45 |
| Operating Expense | 135.76 | 134.28 | 138.74 | 142.37 | 119.51 |
| Operating Profit | 26.69 | 25.78 | 24.44 | 29.63 | 13.95 |
| Depreciation | 3.74 | 3.70 | 3.64 | 3.37 | 3.32 |
| Interest | 7.26 | 7.12 | 7.54 | 9.04 | 10.17 |
| Tax | 0.11 | -0.02 | 0.12 | -1.20 | 0.07 |
| Net Profit | 15.76 | 15.18 | 13.49 | 20.26 | 1.22 |
₹234.83
↗ Bullish Moving Average
5
↘ Bearish Moving Average
11
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 39.8 | 39.8 | 39.8 | 39.6 | 39.6 | 43.1 |
| FII | 1 | 0.8 | 1.6 | 1.6 | 0.8 | 0.7 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 59.2 | 59.4 | 58.7 | 58.8 | 59.6 | 56.2 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.05 L | 1.05 L | 100.00% |
| Week | 67.78 K | 67.78 K | 100.00% |
| 1 Month | 51.28 K | 51.28 K | 100.00% |
| 6 Month | 57.38 K | 1.11 L | 51.72% |
Benjamin Graham Value Screen
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Strong Performer, Under Radar Stocks (DVM)
Profit making Companies with High ROCE and Low PE
Undervalued Growth Stocks
Jim Slater's Zulu Principle (Discover Growth Stocks)
Stocks seeing month price declines, good financial durability, and newly affordable valuations (subscription)
Companies with high TTM EPS Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Companies with rising net profit margins - quarterly as well as TTM basis
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing profits every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with decreasing Promoter pledge
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 29 Jul, 2010 | 1 | FINAL | Equity Share | |
| 12 Mar, 2009 | 0.5 | FINAL | Equity Share | |
| 13 Sep, 2007 | 2 | FINAL | Equity Share | |
| 07 Sep, 2006 | 1.5 | FINAL | Equity Share | |
| 20 Feb, 2006 | 0.5 | INTERIM | 21 Feb, 2006 | Equity Share |
| 28 Jul, 2005 | 1 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹425 | ₹7.01 | ₹105.93 | ₹122.50 | ₹70 | ₹145.72 |
| % Change | 0.77% | 4.94% | -3.20% | 2.60% | 0.92% | -0.31% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹282.74 | - | ₹114.33 | ₹53.14 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹15.30 | - | ₹11.66 | ₹-267.91 |
| PE TTM | - | -1.70 | 26.90 | - | 12.50 | -17.70 |
| 1 Year Return | 7.83 | 601 | -15.85 | 33.64 | -34.36 | 2.16 |
| ROCE | 28.91 | -5.63 | - | - | 14.72 | 862.23 |
SMS Pharmaceuticals Ltd.
₹ 415.00
+0.00%
Nectar Lifesciences Ltd.
₹ 10.74
+0.47%
Mangalam Drugs and Organics Ltd.
₹ 32.49
+1.63%
Indoco Remedies Ltd.
₹ 202.75
+0.66%
Ind-Swift Laboratories Ltd.
₹ 143.48
+0.17%
Lincoln Pharmaceuticals Ltd.
₹ 546.00
-0.34%
Panacea Biotec Ltd.
₹ 322.90
+0.31%
Medicamen Biotech Ltd.
₹ 235.50
-0.61%
Themis Medicare Ltd.
₹ 82.85
+0.47%
Venus Remedies Ltd.
₹ 968.00
-0.92%
Bal Pharma Ltd.
₹ 76.31
-0.51%
Hikal Ltd.
₹ 175.00
+0.14%
NGL Fine - Chem Ltd.
₹ 2378.00
+0.69%
Hester Biosciences Ltd.
₹ 1429.00
+0.04%
Natural Capsules Ltd.
₹ 154.24
-0.03%
Krebs Biochemicals & Industries Ltd.
₹ 57.03
-0.52%
Kilitch Drugs(I) Ltd.
₹ 130.71
-0.43%
Syncom Formulation (India) Ltd.
₹ 12.97
-0.15%
Aarey Drugs & Pharmaceuticals Ltd.
₹ 65.26
+0.00%
Biofil Chemicals & Pharmaceuticals Ltd.
₹ 33.00
-0.54%
Aarti Drugs Ltd.
₹ 357.50
-0.04%
Orchid Pharma Ltd.
₹ 541.00
-0.16%
Kopran Ltd.
₹ 156.00
-0.01%
IOL Chemicals and Pharmaceuticals Ltd.
₹ 80.75
-0.11%
By signing up I certify terms, conditions & privacy policy